The Impact of HAART on the Respiratory Complications of HIV Infection: Longitudinal Trends in the MACS and WIHS Cohorts

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gingo, Matthew R ^a   Balasubramani, G K ^b   Kingsley, Lawrence ^b   Rinaldo, Charles R ^a,b   Alden, Christine B ^c   Detels, Roger ^d   Greenblatt, Ruth M ^e,f   Hessol, Nancy A ^e,f   Holman, Susan ^g   Huang, Laurence ^f   Kleerup, Eric C ^h   Phair, John ⁱ   Sutton, Sarah H ⁱ   Seaberg, Eric C ^c   Margolick, Joseph B ^c   Wisniewski, Stephen R ^b   Morris, Alison ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SUNY Downstate Medical Center   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; VIRUS INFECTIVITY;

EID: 84874873416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058812     Document Type: Article

References (51)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
2. McKenzie R, Travis WD, Dolan SA, Pittaluga S, Feuerstein IM, et al. (1991) The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 70: 326-343.
3. Wallace JM, Hansen NI, Lavange L, Glassroth J, Browdy BL, et al. (1997) Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 155: 72-80.
4. Murray JF, Garay SM, Hopewell PC, Mills J, Snider GL, et al. (1987) NHLBI workshop summary. Pulmonary complications of the Acquired Immunodeficiency Syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis 135: 504-509.
5. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, et al. (2006) Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 130: 1326-1333.
6. Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, et al. (2011) HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 183: 388-395.
7. Grubb JR, Moorman AC, Baker RK, Masur H, (2006) The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 20: 1095-1107.
8. Bower M, Powles T, Nelson M, Shah P, Cox S, et al. (2003) HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17: 371-375.
9. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, et al. (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21: 3447-3453.
10. Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, et al. (2004) Cancer risk among participants in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 36: 978-985.
11. Hsue PY, Deeks SG, Farah HH, Palav S, Ahmed SY, et al. (2008) Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 22: 825-833.
12. Sitbon O, Lascoux-Combe C, Delfraissy J-F, Yeni PG, Raffi F, et al. (2008) Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 177: 108-113.
13. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, et al. (2000) Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30Suppl 1: S5-14.
14. Moore RD, Chaisson RE, (1999) Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13: 1933-1942.
15. Dufour V, Cadranel J, Wislez M, Lavole A, Bergot E, et al. (2004) Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy. Lung 182: 331-341.
16. Gingo MR, George MP, Kessinger CJ, Lucht L, Rissler B, et al. (2010) Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 182: 790-796.
17. Hariri S, McKenna MT, (2007) Epidemiology of Human Immunodeficiency Virus in the United States. Clin Microbiol Rev 20: 478-488.
18. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, et al. (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126: 310-318.
19. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, et al. (1998) The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9: 117-125.
20. DHHS/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. (November 3, 2008 revision) Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents.
21. Diggle P, Liang K-Y, Zeger SL (1994) Analysis of longitudinal data. New York: Clarendon Press; Oxford University Press. XI, 253.
22. Hardin JW, Hilbe J (2003) Generalized estimating equations. Boca Raton, Fla.: Chapman & Hall/CRC. XIII, 222.
23. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, et al. (1995) Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 333: 845-851.
24. Seaberg EC, Wiley D, Martinez-Maza O, Chmiel JS, Kingsley L, et al. (2011) Cancer incidence in the Multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 116: 5507-5516.
25. Foster SB, McIntosh K, Thompson B, Lu M, Yin W, et al. (2008) Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol 122: 159-165.
26. Gutin F, Butt A, Alame W, Thomas R, Secord E, (2009) Asthma in immune-competent children with human immunodeficiency virus. Ann Allergy Asthma Immunol 102: 438.
27. Gingo MR, Wenzel SE, Steele C, Kessinger CJ, Lucht L, et al. (2012) Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J Allergy Clin Immunol. 129: 708-714.
28. Allardice GM, Hole DJ, Brewster DH, Boyd J, Goldberg DJ, (2003) Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer 89: 505-507.
29. Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, et al. (2007) Elevated risk of lung cancer among people with AIDS. AIDS 21: 207-213.
30. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, et al. (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425-432.
31. Dal Maso L, Polesel J, Serraino D, Franceschi S, (2003) Lung cancer in persons with AIDS in Italy, 1985-1998. AIDS 17: 2117-2119.
32. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, et al. (2006) Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 24: 1383-1388.
33. Frisch M, Biggar RJ, Engels EA, Goedert JJ, (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736-1745.
34. Kirk GD, Merlo C, P OD, Mehta SH, Galai N, et al. (2007) HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 45: 103-110.
35. Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, et al. (2001) Cancer incidence in women with or at risk for HIV. Int J Cancer 94: 753-757.
36. Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, et al. (2012) HIV as an independent risk factor for incident lung cancer. AIDS 26: 1017-1025.
37. D'Jaen GA, Pantanowitz L, Bower M, Buskin S, Neil N, et al. (2010) Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer 11: 396-404.
38. Shiels MS, Cole SR, Mehta SH, Kirk GD, (2010) Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr 55: 510-515.
39. Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. (2011) Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer 11: 272.
40. Almirall J, Bolibar I, Balanzo X, Gonzalez CA, (1999) Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 13: 349-355.
41. Balbi B, Cottin V, Singh S, De Wever W, Herth FJ, et al. (2010) Smoking-related lung diseases: a clinical perspective. Eur Respir J 35: 231-233.
42. CDC (2006) Epidemiology of HIV/AIDS-United States, 1981-2005. MMWR Morb Mortal Wkly Rep 55: 589-592.
43. Gouws E, White PJ, Stover J, Brown T, (2006) Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 82Suppl 3: iii51-55.
44. Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, et al. (2001) HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA: the journal of the American Medical Association 286: 2560-2567.
45. Crothers K, Goulet JL, Rodriguez-Barradas MC, Gibert CL, Butt AA, et al. (2007) Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 22: 749-754.
46. Johannessen A, Omenaas E, Bakke P, Gulsvik A, (2005) Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 9: 926-932.
47. Lindberg A, Bjerg A, Ronmark E, Larsson LG, Lundback B, (2006) Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 100: 264-272.
48. Takahashi T, Ichinose M, Inoue H, Shirato K, Hattori T, et al. (2003) Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 8: 504-508.
49. Celli BR, Halbert RJ, Nordyke RJ, Schau B, (2005) Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 118: 1364-1372.
50. Coultas DB, Mapel D, Gagnon R, Lydick E, (2001) The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 164: 372-377.
51. CDC (2005) Cigarette smoking among adults-United States, 2004. MMWR Morb Mortal Wkly Rep 54: 1121-1124.